1. Kuukasjärvi, Anna, Landoni, Juan C, Kaukonen, Jyrki, Velagapudi, Vidya, Suomalainen, Anu. 2021. IMPDH2: a new gene associated with dominant juvenile-onset dystonia-tremor disorder. In European journal of human genetics : EJHG, 29, 1833-1837. doi:10.1038/s41431-021-00939-1. https://pubmed.ncbi.nlm.nih.gov/34305140/
2. Duan, Shiyu, Huang, Wenqing, Liu, Xiaoting, Song, Wen, Zhou, Jun. 2018. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways. In Journal of experimental & clinical cancer research : CR, 37, 304. doi:10.1186/s13046-018-0980-3. https://pubmed.ncbi.nlm.nih.gov/30518405/
3. Huang, Yuting, Chan, Szehoi, Chen, Shuna, Zhang, Xingding, Zhang, Bo. 2024. Wnt/β-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in colorectal cancer. In Journal of translational medicine, 22, 133. doi:10.1186/s12967-024-04934-0. https://pubmed.ncbi.nlm.nih.gov/38310229/
4. Sugimoto, Atsuko, Watanabe, Takahiro, Matsuoka, Kazuhiro, Kimura, Hiroshi, Murata, Takayuki. 2023. Growth Transformation of B Cells by Epstein-Barr Virus Requires IMPDH2 Induction and Nucleolar Hypertrophy. In Microbiology spectrum, 11, e0044023. doi:10.1128/spectrum.00440-23. https://pubmed.ncbi.nlm.nih.gov/37409959/